Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Glenmark Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - GLENMARK PHARMACEUTICALS LTD (GLENMARK-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Mar 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Glenmark Pharmaceuticals Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Mar 2015 Wright Reports 56 $75.00

MOSL: GLENMARK PHARMA (Buy) - Forex hit mars 3Q performance - imminent US launches to bolster growth

GLENMARK PHARMA 3QFY15: Forex hit mars 3Q performance; imminent US launches to bolster growth (GNP IN, Mkt Cap USD3.2b, CMP ...

16 Feb 2015 Motilal Oswal Securities Ltd. 12 $127.00

Glenmark Pharmaceuticals (GNP) - Qtr. Update - Dated - February 13, 2015

Glenmark Pharma (Bloomberg: GNP IN, BUY, TP – Rs 860, 12% upside from CMP of Rs 767) GNP’s Q3 PAT (-47% YoY) was 43% below...

13 Feb 2015 Axis Capital Limited 9 $92.00

Glenmark Pharmaceuticals Ltd.|Q3FY15 Result/Concall Update | A weak quarter; however, outlook is promising | Maintain HOLD rating with PT of Rs795 (from Rs775 earlier)

Glenmark Pharmaceuticals Ltd.|Q3FY15 Result/Concall Update A weak quarter; however, outlook is promising | Maintain HOLD rat...

13 Feb 2015 IndiaNivesh Securities Pvt Ltd 5 $46.00

GLEN.NS - Event Transcript of Glenmark Pharmaceuticals Ltd conference call, Feb. 12, 2015 / 10:00PM ET

Edited Event Transcript of GLEN.NS conference call, Feb. 12, 2015 / 10:00PM ET Boston, Feb 13, 2015 (Thomson StreetEven...

12 Feb 2015 Thomson Reuters StreetEvents 27 $75.00

Glenmark Pharmaceuticals Ltd: Upgraded to Above Average

03 Feb 2015 Sadif Analytics Prime 3 $10.00

Should Investors Steer Clear of the Glenmark Pharmaceuticals Ltd?

08 Jan 2015 Sadif Analytics Prime 11 $25.00

MOSL: GLENMARK PHARMA - Better days ahead as US launches expected to revive- Upgrade to Buy

GLENMARK PHARMA 2QFY15: Weak operational performance, better days ahead as US launches expected to revive (GNP IN, Mkt Cap U...

03 Nov 2014 Motilal Oswal Securities Ltd. 8 $81.00